Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Cbmg Holdings Completes $120 Million In Series A Funding, Accelerating Development Of Car-T Therapy Pipelines And R&D For Innovative Solid Tumor Therapies
Cbmg Holdings Completes $120 Million In Series A Funding, Accelerating Development Of Car-T Therapy Pipelines And R&D For Innovative Solid Tumor Therapies
Company Info
Company news
Fri, 19 Feb 2021 08:00:00 GMT
Cellular Biomedicine Group, Inc. Announces Completion of Merger - PR Newswire
Wed, 12 Aug 2020 07:00:00 GMT
Cellular Biomedicine Group (CBMG) Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private - PR Newswire
Mon, 20 Nov 2023 08:00:00 GMT
CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc. - PR Newswire
Wed, 02 Oct 2019 07:00:00 GMT
Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development - PR Newswire
Mon, 13 Jul 2020 07:00:00 GMT
Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical Programs - PR Newswire
Thu, 30 Sep 2021 07:00:00 GMT
CBMG Holdings Completes $120 Million in Series A Funding, Accelerating Development of CAR-T Therapy Pipelines and R&D for Innovative Solid Tumor Therapies - PR Newswire
Thu, 27 Sep 2018 07:00:00 GMT
Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China - PR Newswire
Tue, 02 May 2023 07:00:00 GMT
Cellular Biomedicine Group Announces Exclusive Collaboration and License Agreement with Janssen to Develop and Commercialize anti CD19 & CD20 Bi-Specific and anti CD20 CAR-Ts for Non-Hodgkin Lymphoma - PR Newswire
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.